Outcome comparison of mitral valve surgery and MitraClip therapy in patients with severely reduced left ventricular dysfunction
Open Access
- 23 May 2020
- journal article
- research article
- Published by Wiley in ESC Heart Failure
- Vol. 7 (4), 1781-1790
- https://doi.org/10.1002/ehf2.12741
Abstract
Aims The aim of this study was to compare the outcomes of surgical mitral valve repair or replacement (sMVR) and percutaneous edge‐to‐edge repair using MitraClip (pMVR) in patients with severe left ventricular dysfunction affected by functional mitral regurgitation (FMR). Methods and results We retrospectively identified 132 patients with left ventricular ejection fraction (LVEF) ≦ 30% submitted to sMVR (n = 47) or pMVR (n = 85) for FMR at our centre from January 2013 to December 2017. To adjust for baseline imbalances, we used a propensity score matching by age, logistic EuroSCORE, and left ventricular end‐systolic volume. After being matched, MitraClip therapy showed lower perioperative mortality and rate of complications yet increased residual mitral regurgitation (MR) grade than did surgery (0.2 ± 0.50 in sMVR vs. 1.3 ± 0.88 in pMVR, P < 0.0001). According to stratified multivariate Cox model analysis, residual MR severity was an independent risk factor for cardiac death [hazard ratio (HR), 2.81; 95% confidence interval [CI], 1.44–5.48, P = 0.0025] and re‐hospitalization for heart failure (HR, 3.07; 95% CI, 1.50–6.29, P = 0.0022) at 1 year follow‐up. Stratified multivariable Cox regression analysis at 3 years identified pMVR as risk factor for cardiac death (HR, 0.19; 95% CI, 0.040–0.86, P = 0.031) and re‐hospitalization for heart failure (HR, 0.28; 95% CI, 0.077–0.99, P = 0.048). Conclusions In patients with FMR and LVEF ≤ 30%, MitraClip therapy resulted in lower perioperative complications and mortality than sMVR. However, surgically treated patients who survived the perioperative stage had less residual MR and experienced lower rates of re‐hospitalization for heart failure at 1 year and lower cardiac mortality at 1 and 3 years of follow‐up than did patients undergoing pMVR.Keywords
This publication has 26 references indexed in Scilit:
- Prevalence and Outcomes of Unoperated Patients With Severe Symptomatic Mitral Regurgitation and Heart FailureJournal of the American College of Cardiology, 2014
- Percutaneous Mitral Valve Interventions in the Real World: Early and 1-Year Results From the ACCESS-EU, A Prospective, Multicenter, Nonrandomized Post-Approval Study of the MitraClip Therapy in EuropeJournal of the American College of Cardiology, 2013
- Interventionelle Behandlung der Mitralklappeninsuffizienz mit dem MitraClip®-VerfahrenDer Kardiologe, 2013
- MitraClip therapy in daily clinical practice: initial results from the German transcatheter mitral valve interventions (TRAMI) registryEuropean Journal of Heart Failure, 2012
- Percutaneous mitral valve repair with the MitraClip system: acute results from a real world settingEuropean Heart Journal, 2010
- Failure of Guideline Adherence for Intervention in Patients With Severe Mitral RegurgitationJournal of the American College of Cardiology, 2009
- Mitral valve surgery for functional mitral regurgitation: prognostic role of tricuspid regurgitation☆European Journal of Cardio-Thoracic Surgery, 2009
- What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery?European Heart Journal, 2007
- Determinants of the Degree of Functional Mitral Regurgitation in Patients With Systolic Left Ventricular DysfunctionCirculation, 2000
- Risk stratification for cardiac valve replacement. National Cardiac Surgery DatabaseThe Annals of Thoracic Surgery, 1999